≡

ELISA Kit for Glia Derived Nexin (GDN)

SERPINE2; PI7; PN1; PNI; Protease Nexin I; Serpin Peptidase Inhibitor Clade E Member 2; Peptidase inhibitor 7; Protease nexin I

Specificity

This assay has high sensitivity and excellent specificity for detection of Glia Derived Nexin (GDN).
No significant cross-reactivity or interference between Glia Derived Nexin (GDN) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Glia Derived Nexin (GDN) and the recovery rates were calculated by comparing the measured value to the expected amount of Glia Derived Nexin (GDN) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-91 86
EDTA plasma(n=5) 86-97 94
heparin plasma(n=5) 85-96 88

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glia Derived Nexin (GDN) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Glia Derived Nexin (GDN) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Glia Derived Nexin (GDN) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 98-105% 99-105% 80-105% 78-91%
EDTA plasma(n=5) 88-98% 86-99% 88-101% 97-105%
heparin plasma(n=5) 85-92% 90-98% 93-101% 97-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Medical Sciences Graduate Program Clinical Biomarkers for the Noninvasive Diagnosis of Endometriosis handle:11375
ScientificReports The Involvement of Protease Nexin-1 (PN1) in the Pathogenesis of Intervertebral Disc (IVD) Degeneration pubmed:27460424
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPD381Hu01 Recombinant Glia Derived Nexin (GDN) Positive Control; Immunogen; SDS-PAGE; WB.
PAD381Hu01 Polyclonal Antibody to Glia Derived Nexin (GDN) WB; IHC; ICC; IP.
MAD381Hu21 Monoclonal Antibody to Glia Derived Nexin (GDN) WB; IHC; ICC; IP.
WED381Hu Wide-range ELISA Kit for Glia Derived Nexin (GDN) Enzyme-linked immunosorbent assay for Antigen Detection.
SED381Hu ELISA Kit for Glia Derived Nexin (GDN) Enzyme-linked immunosorbent assay for Antigen Detection.
LMD381Hu Multiplex Assay Kit for Glia Derived Nexin (GDN) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.